Recursion Pharmaceuticals shares owned by Duquesne Family Office
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Duquesne Family Office
from 13F filings
Historical chart of Duquesne Family Office investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Duquesne Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.9M | 907k | 9.86 |
| 2023-09-30 | $6.9M | 907k | 7.65 |
| 2023-06-30 | $10M | 1.4M | 7.47 |
| 2023-03-31 | $9.3M | 1.4M | 6.68 |
| 2022-12-31 | $11M | 1.4M | 7.71 |
| 2022-09-30 | $15M | 1.4M | 10.64 |
| 2022-06-30 | $2.2M | 274k | 8.14 |
| 2022-03-31 | $2.0M | 274k | 7.16 |
| 2021-12-31 | $4.5M | 260k | 17.13 |
| 2021-09-30 | $6.0M | 260k | 23.01 |